Icahn School of Medicine at Mount Sinai: Crohn Disease trials

The registry lists 10 Crohn Disease studies with Icahn School of Medicine at Mount Sinai as lead sponsor. 3 are open to participants now and 2 have results posted.

Phase 1 1Phase 4 2No phase 7(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• MIRICURE: Mirikizumab With Curettage and Repair (Closure) for Perianal Fistulizing Crohn's DiseaseNot yet recruitingNCT07782021Phase 4
• Behavioral Therapy for Crohn's DiseaseRecruitingNCT06512597Not applicable
• Pregnant Women With and Without Crohns Disease to Explore the Role of Plastics and Toxins in Intestinal InflammationRecruitingNCT06001450
• The Use of Small Bowel Ultrasound to Predict Response to Remicade InductionCompletedNCT02488005Not applicableResults posted
• Corticosteroids With Vedolizumab in Crohn's DiseaseTerminatedNCT02324699Phase 4Results posted
• Study to Evaluate Safety, Tolerability and Efficacy of Oral E-B-FAHF-2 in Mild-to-Moderate Crohn's DiseaseActive, not recruitingNCT03992469Phase 1
• Modulating Early Life Microbiome Through Dietary Intervention in Crohn's DiseaseActive, not recruitingNCT03850600Not applicable
• The Impact of Anti-TNF Exposure on Vedolizumab EffectivenessCompletedNCT02423512
• Trial on Impact of HealthPROMISE Mobile App on Inflammatory Bowel Disease Care and Quality of LifeCompletedNCT02322307Not applicable
• Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel DiseaseCompletedNCT02054533